Use of Postop Sling After Biceps Tenodesis

Sponsor
University Hospitals Cleveland Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05558579
Collaborator
(none)
150
1
2
20.4
7.4

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate whether the use of a sling after surgery (biceps tenodesis) is required in recovery and rehabilitation. Biceps tenodesis is one of the most common surgeries for patients who have biceps tendon inflammation and/or instability, rotator cuff tears, and labral tears that do not get better with medications or physical therapy. A biceps tenodesis involves cutting the biceps tendon and reconnecting it to the shoulder with sutures or metal screws. After surgery, most patients are required to wear a shoulder sling and limit certain arm motions to protect the healing tendon. A recent study found using a more flexible rehabilitation protocol for biceps tenodesis did not change outcomes (strength or range-of-motion) and allows patients to return to some regular activities earlier. This data suggests patients may not need to wear a sling after surgery. Therefore, this study aims to evaluate this.

This study will have two groups-one that continues to wear the sling, and one that does not. Patients will be randomly assigned to one of these groups. At each follow-up visit after surgery, shoulder strength and range-of-motion will be measured and several surveys about shoulder function will be completed. These surveys will provide information to compare between both groups. If assigned to the group that wears the sling, patients will record how often they are wearing the sling in a paper diary/log. Additionally, at the 6-month follow-up, an ultrasound will be obtained to make sure the tendon is healing properly regardless of which group patients are assigned to. Finally, medical history will be collected to identify protective and risk factors for any differences that might be found.

Condition or Disease Intervention/Treatment Phase
  • Other: No sling use
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Postoperative Sling Use in Patient Outcomes After Isolated Biceps Tenodesis
Anticipated Study Start Date :
Jan 15, 2023
Anticipated Primary Completion Date :
Sep 26, 2024
Anticipated Study Completion Date :
Sep 26, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Patients Using Sling

Patients will continue using shoulder sling per standard of care

Experimental: Patients Without Sling

Patients will not use shoulder sling postoperatively.

Other: No sling use
Patients will not use standard of care sling

Outcome Measures

Primary Outcome Measures

  1. Percent of Complications As Measured by Medical Records [Up to 2 years]

  2. Degrees of Range-of-Motion As Measured by Physical Exam [Up to 30 minutes]

  3. Strength as Measured by Physical Exam [Up to 30 minutes]

    Strength is measured on a 5-point scale with 0 being no discernible muscle contraction and 5 being muscle contraction and maximum resistance

Secondary Outcome Measures

  1. Pain as Measured by the Visual Analog Scale [Up to 5 minutes]

    VAS is a 10-point scale with 0 being no pain and 10 being worst possible pain

  2. Shoulder Function as Measured by the American Shoulder and Elbow Surgeons (ASES) [Up to 15 minutes]

    ASES is a 17-item survey that has a score from 0-100

  3. Shoulder Function as Measured by the Simple Shoulder Test (SST) [Up to 15 minutes]

    SST is a 12-item survey that has a score up to 12 points

  4. Shoulder Function as Measured by Constant Murley Score (CMS) [Up to 15 minutes]

    CMS is scored up to 100 points maximum

  5. Shoulder Function as Measured by the Western Ontario Rotator Cuff (WORC) Index [Up to 15 minutes]

    WORC is a 21-item survey scored on a scale from 2,100 to 0

  6. Shoulder Function as Measured by the Single Assessment Numeric Evaluation (SANE) [Up to 5 minutes]

    SANE is a 1-item survey that has a score from 0-100

  7. Percent of Patients Satisfied as Measured by Patient Survey [Up to 5 minutes]

    Yes/no survey asking about satisfaction with care

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who undergo open or arthroscopic isolated BT for diagnoses including but not limited to biceps tendinitis or tenosynovitis, biceps tendon tears, partial-thickness rotator cuff tears, subacromial bursitis, superior labrum from anterior to posterior (SLAP) tear, biceps instability

  • Patients with minimum 6-month follow-up

Exclusion Criteria:
  • Patients who undergo any concomitant procedures necessitating ROM restrictions, including but not limited to rotator cuff repair, labral repair, SLAP lesion repair, or shoulder arthroplasty

  • Patients with history of prior ipsilateral proximal biceps procedures

  • Patients with history of conditions resulting in severe shoulder strength and ROM limitations (e.g. severe degenerative glenohumeral osteoarthritis, polymyalgia rheumatica, cervical radiculopathy, significant muscle paralysis, etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospitals Cleveland Ohio United States 44106

Sponsors and Collaborators

  • University Hospitals Cleveland Medical Center

Investigators

  • Principal Investigator: Michael Karns, MD, University Hospitals
  • Principal Investigator: Kallie Chen, MD, University Hospitals

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Karns, MD., Assistant Professor, University Hospitals Cleveland Medical Center
ClinicalTrials.gov Identifier:
NCT05558579
Other Study ID Numbers:
  • STUDY20220856
First Posted:
Sep 28, 2022
Last Update Posted:
Dec 13, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Michael Karns, MD., Assistant Professor, University Hospitals Cleveland Medical Center

Study Results

No Results Posted as of Dec 13, 2022